Aug 14, 2025 04:05PM
Jul 8, 2025 08:50AM
Jul 7, 2025 08:32AM
Jul 7, 2025 08:30AM
May 15, 2025 04:05PM
Mar 31, 2025 04:05PM
Nov 14, 2024 04:10PM Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Nov 7, 2024 08:32AM
Nov 7, 2024 08:30AM
Aug 13, 2024 04:05PM
Jun 17, 2024 08:31AM
Jun 17, 2024 08:30AM
May 15, 2024 04:15PM
May 14, 2024 06:55AM Mustang Bio (MBIO) PT Lowered to $2 at H.C. Wainwright
Mar 28, 2024 04:05PM
Mar 11, 2024 04:05PM
Mar 7, 2024 07:05AM
Mar 7, 2024 05:00AM
Dec 11, 2023 08:31AM
Dec 11, 2023 08:30AM
Nov 14, 2023 04:10PM Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
Nov 14, 2023 04:05PM
Nov 2, 2023 09:28AM
Oct 26, 2023 09:03AM
Oct 26, 2023 09:00AM
Aug 16, 2023 08:01AM
Aug 16, 2023 08:00AM
Aug 14, 2023 04:05PM Mustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Aug 14, 2023 04:01PM
Jun 12, 2023 08:03AM
Jun 12, 2023 08:00AM
May 15, 2023 04:01PM
May 12, 2023 04:05PM
Mar 30, 2023 04:10PM
Mar 29, 2023 04:15PM Mustang Bio Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
Dec 19, 2022 08:31AM
Dec 19, 2022 08:30AM
Nov 14, 2022 04:05PM
Nov 14, 2022 04:01PM
Oct 27, 2022 08:04AM
Oct 27, 2022 08:00AM
Oct 6, 2022 08:30AM Mustang Bio Announces First Patient Treated in Its Multicenter Phase 1/2 Clinical Trial of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy to Treat B-cell Non-Hodgkin Lymphoma an
Aug 11, 2022 04:30PM
Aug 11, 2022 04:05PM
Jun 22, 2022 08:00AM
Jun 22, 2022 08:00AM
Jun 22, 2022 08:00AM
May 12, 2022 04:05PM
May 12, 2022 04:05PM Mustang Bio Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
May 12, 2022 04:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All